Suppression of glioblastoma by targeting the overactivated protein neddylation pathway

BACKGROUND: The neddylation pathway has been recently identified as an attractive anticancer target, and MLN4924, a specific NEDD8-activating enzyme inhibitor, has been developed as a first-in-class anticancer agent. However, neither the status of the neddylation pathway in glioblastoma (GBM) nor th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Hua, Wei, Li, Chunjie, Yang, Zixiao, Li, Lihui, Jiang, Yanan, Yu, Guangyang, Zhu, Wei, Liu, Zhengyan, Duan, Shengzhong, Chu, Yiwei, Yang, Meng, Zhang, Yanmei, Mao, Ying, Jia, Lijun
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578582/
https://ncbi.nlm.nih.gov/pubmed/25904638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov066
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars